Accuray announces FDA clearance of iDMS Data Management System

Michael Walter | | Radiology Business | Medical Imaging

Accuray, a Sunnyvale, California-based radiation oncology company, announced Monday that it has received 510(k) clearance from the FDA for its iDMS Data Management System, a database that shares data between different Accuray delivery systems. The company views this new database as an upgrade to its entire TomoTherapy platform.

Lionel Hadjadjeba, Accuray’s senior vice president and chief commercial officer, said in a prepared statement that this makes the lives of specialists using Accuray’s solutions much easier.

“This most recent clearance reinforces Accuray's commitment to providing clinicians with options for seamless, fully integrated treatment planning and data management, enhancing department workflow efficiency,” Hadjadjeba said. “The common database will make it possible for clinicians to use any available Accuray treatment system, expanding patient access to the precision and treatment versatility of our advanced radiation therapy systems.”

The iDMA Data Management System was developed to integrate with numerous Accuray solutions, including the Radixact Treatment Delivery System, Accuray Precision™ Treatment Planning System and others.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Radiologists are more accurate, confident when they know the full story
GE HealthCare moves PET/CT scanner production to United States
Use of AI opportunistic screening in CT for cardiovascular disease

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.